These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11564050)

  • 1. Therapeutic drug monitoring: antiarrhythmic drugs.
    Campbell TJ; Williams KM
    Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):21S-34S. PubMed ID: 11564050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring: antiarrhythmic drugs.
    Campbell TJ; Williams KM
    Br J Clin Pharmacol; 1998 Oct; 46(4):307-19. PubMed ID: 9803978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic agents and proarrhythmia.
    Chaudhry GM; Haffajee CI
    Crit Care Med; 2000 Oct; 28(10 Suppl):N158-64. PubMed ID: 11055685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.
    Snider M; Kalbfleisch S; Carnes CA
    Clin Ther; 2009 Jun; 31(6):1209-18. PubMed ID: 19695388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic Drug Monitoring of Antiarrhythmic Drugs].
    Takahashi N
    Rinsho Byori; 2016 Dec; 64(12):1390-1394. PubMed ID: 30653903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benefit-risk assessment of class III antiarrhythmic agents.
    Brendorp B; Pedersen O; Torp-Pedersen C; Sahebzadah N; Køber L
    Drug Saf; 2002; 25(12):847-65. PubMed ID: 12241126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring.
    Takada M; Goto T; Kotake T; Saito M; Kawato N; Nakai M; Gunji T; Shibakawa M
    J Clin Pharm Ther; 2005 Feb; 30(1):5-12. PubMed ID: 15658999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class III antiarrhythmics in overdose. Presenting features and management principles.
    Leatham EW; Holt DW; McKenna WJ
    Drug Saf; 1993 Dec; 9(6):450-62. PubMed ID: 8129865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of antiarrhythmic drugs.
    Frumin H; Kerin NZ; Rubenfire M
    J Clin Pharmacol; 1989 May; 29(5):387-94. PubMed ID: 2661597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification and mechanism of action of antiarrhythmic drugs.
    Scholz H
    Fundam Clin Pharmacol; 1994; 8(5):385-90. PubMed ID: 7875632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions.
    Nattel S; Singh BN
    Am J Cardiol; 1999 Nov; 84(9A):11R-19R. PubMed ID: 10568655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drugs: present and future.
    Sharma S
    J Assoc Physicians India; 2007 Apr; 55 Suppl():43-6. PubMed ID: 18368867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially significant drug interactions of class III antiarrhythmic drugs.
    Yamreudeewong W; DeBisschop M; Martin LG; Lower DL
    Drug Saf; 2003; 26(6):421-38. PubMed ID: 12688833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of serum drug level monitoring during therapy with class III antiarrhythmic agents.
    Follath F
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S41-3. PubMed ID: 1279308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent antiarrhythmic drugs.
    Jaillon P; Drici M
    Am J Cardiol; 1989 Dec; 64(20):65J-69J. PubMed ID: 2688391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaughan Williams class IV antiarrhythmic drugs].
    Horie M; Washizuka T; Ikeguchi S; Sasayama S
    Nihon Rinsho; 1996 Aug; 54(8):2132-7. PubMed ID: 8810788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
    Bjørnstad H; Refsum H
    Tidsskr Nor Laegeforen; 1991 Oct; 111(26):3187-9. PubMed ID: 1658976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic agents: drug interactions of clinical significance.
    Trujillo TC; Nolan PE
    Drug Saf; 2000 Dec; 23(6):509-32. PubMed ID: 11144659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.